UNSPSC 51283953: Sulfaquinoxaline sodium

This classification denotes a sulfonamide anti-infective agent with the molecular formula C14H11N4O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21223EPJ40, chemically known as n1-(quinoxalin-2-yl)sulphanilamide sodium salt, but more generally known as sulfaquinoxaline sodium, which bears US NIH Compound Identifier 71594. European Medicines Agency schedules sulfaquinoxaline sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10725MIG.

Most nations, for tariff purposes, schedule sulfaquinoxaline sodium under HS 29350090. Sulfaquinoxaline sodium bears US NLM identifiers UMLS ID C2728210 and NCI Concept Code C90992. SMILES: C1CCC2C(C1)NCC(N2)[N-]S(=O)(=O)C3CCC(CC3)N.[NA+].

UNSPSC 51283953 Sulfaquinoxaline sodium is a Commodity code that captures pharmaceutical products procured by state and local health agencies. Based on recent contract opportunities, state and local governments use this code to source specific pharmaceutical agents for public health programs, emergency response initiatives, and disease prevention. The issuing bodies include state departments of public health and county health authorities, which typically procure through competitive bidding processes or piggyback arrangements on established pharmaceutical supply contracts. These agencies purchase pharmaceuticals in bulk for distribution through public health infrastructure, including community health buildings and emergency preparedness programs.

Recent activity shows procurement concentrated in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for a total of $2,999,999.11 over the contract life, though this award involved Doxycycline Hyclate and Ciprofloxacin Hydrochloride rather than sulfaquinoxaline sodium itself. Seminole County, Florida issued an IFB (Solicitation Number IFB60459723LAS) posted June 30, 2026 with a response deadline of July 26, 2026 (later noted as July 26, 2023 in the source document) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries required to the Seminole County Community Health Building. The code shows limited recent direct activity specifically targeting sulfaquinoxaline sodium; the opportunities tagged to this code predominantly reflect other pharmaceutical agents, suggesting either limited current demand for this specific product or tagging inconsistency within state and local procurement systems.